An integrative framework identifies alternative splicing events in colorectal cancer development

Molecular Oncology

Volumn 8, Issue 1, 2014, Pages 129-141

  Bisognin, Andrea ^a   Pizzini, Silvia ^a   Perilli, Lisa ^a   Esposito, Giovanni ^b   Mocellin, Simone ^a   Nitti, Donato ^a   Zanovello, Paola ^a,b   Bortoluzzi, Stefania ^a   Mandruzzato, Susanna ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Alternative splicing; Colorectal cancer; Exon arrays

Indexed keywords

MESSENGER RNA; RNA; TRANSCRIPTOME;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; B3GNT6 GENE; CALD1 GENE; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CELL INTERACTION; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CARCINOMA; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; CTHRC1 GENE; DNA MICROARRAY; EXON; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENETIC ALGORITHM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MIDDLE AGED; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA ANALYSIS; TUMOR GENE; VCL GENE;

ALTERNATIVE SPLICING; ALTERNATIVELY SPLICED EXONS; ASES; COLORECTAL CANCER; EXON ARRAYS; LIVER METASTASIS; M; N; NCRNAS; NON-CODING RNAS; NORMAL COLON MUCOSA; PRIMARY COLORECTAL CANCER; T;

AGED; ALTERNATIVE SPLICING; COLON; COLORECTAL NEOPLASMS; EXONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECTUM;

EID: 84893022471     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.10.004     Document Type: Article

References (51)

1. Akgul C., Moulding D.A., Edwards S.W. Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications. Cell. Mol. Life Sci. CMLS 2004, 61:2189-2199.
2. Birkenkamp-Demtroder K., Olesen S.H., Sorensen F.B., Laurberg S., Laiho P., Aaltonen L.A., Orntoft T.F. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005, 54:374-384.
3. Bisognin A., Sales G., Coppe A., Bortoluzzi S., Romualdi C. MAGIA(2): from miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update). Nucleic Acids Res. 2012, 40:W13-W21.
4. Brinkman B.M. Splice variants as cancer biomarkers. Clin. Biochem. 2004, 37:584-594.
5. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim. biophys. acta 1999, 1473:67-95.
6. Cancer Genome Atlas, N Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337.
7. Cardoso J., Boer J., Morreau H., Fodde R. Expression and genomic profiling of colorectal cancer. Biochim. biophys. acta 2007, 1775:103-137.
8. Cragg M.S., Chan H.T., Fox M.D., Tutt A., Smith A., Oscier D.G., Hamblin T.J., Glennie M.J. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Blood 2002, 100:3068-3076.
9. Ellis J.D., Barrios-Rodiles M., Colak R., Irimia M., Kim T., Calarco J.A., Wang X., Pan Q., O'Hanlon D., Kim P.M., Wrana J.L., Blencowe B.J. Tissue-specific alternative splicing remodels protein-protein interaction networks. Mol. Cell 2012, 46:884-892.
10. Emig D., Salomonis N., Baumbach J., Lengauer T., Conklin B.R., Albrecht M. AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res. 2010, 38:W755-W762.
11. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
12. Gardina P.J., Clark T.A., Shimada B., Staples M.K., Yang Q., Veitch J., Schweitzer A., Awad T., Sugnet C., Dee S., Davies C., Williams A., Turpaz Y. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006, 7:325.
13. Germann S., Gratadou L., Dutertre M., Auboeuf D. Splicing programs and cancer. J. Nucleic Acids 2012, 2012:269570.
14. Gleisner A.L., Choti M.A., Assumpcao L., Nathan H., Schulick R.D., Pawlik T.M. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch. Surg. 2008, 143:1204-1212.
15. Goehe R.W., Shultz J.C., Murudkar C., Usanovic S., Lamour N.F., Massey D.H., Zhang L., Camidge D.R., Shay J.W., Minna J.D., Chalfant C.E. hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing. J. Clin. Invest. 2010, 120:3923-3939.
16. Gutschner T., Hammerle M., Eissmann M., Hsu J., Kim Y., Hung G., Revenko A., Arun G., Stentrup M., Gross M., Zornig M., MacLeod A.R., Spector D.L., Diederichs S. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013, 73:1180-1189.
17. Habermann J.K., Bader F.G., Franke C., Zimmermann K., Gemoll T., Fritzsche B., Ried T., Auer G., Bruch H.P., Roblick U.J. From the genome to the proteome-biomarkers in colorectal cancer. Langenbeck's arch. surg./Deutsche Gesellschaft Chirurgie 2008, 393:93-104.
18. Iwai T., Kudo T., Kawamoto R., Kubota T., Togayachi A., Hiruma T., Okada T., Kawamoto T., Morozumi K., Narimatsu H. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc. Natl. Acad. Sci. U S A 2005, 102:4572-4577.
19. Jemal A., Ward E., Hao Y., Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA J. Am. Med. Assoc. 2005, 294:1255-1259.
20. Kim Y.S. Mucin glycoproteins in colonic neoplasia. Keio J. Med. 1998, 47:10-18.
21. Kohler C. Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases. Virchows Arch. 2011, 459:81-89.
22. Kornblihtt A.R., Schor I.E., Allo M., Dujardin G., Petrillo E., Munoz M.J. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nature reviews. Mol. Cell Biology 2013, 14:153-165.
23. LaPointe L.C., Dunne R., Brown G.S., Worthley D.L., Molloy P.L., Wattchow D., Young G.P. Map of differential transcript expression in the normal human large intestine. Physiol. Genomics 2008, 33:50-64.
24. Lin J.J., Li Y., Eppinga R.D., Wang Q., Jin J.P. Chapter 1: roles of caldesmon in cell motility and actin cytoskeleton remodeling. Int. Rev. Cell Mol. Biol. 2009, 274:1-68.
25. Lionetti M., Biasiolo M., Agnelli L., Todoerti K., Mosca L., Fabris S., Sales G., Deliliers G.L., Bicciato S., Lombardi L., Bortoluzzi S., Neri A. Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 2009, 114:e20-e26.
26. Miura K., Fujibuchi W., Sasaki I. Alternative pre-mRNA splicing in digestive tract malignancy. Cancer Sci. 2011, 102:309-316.
27. Miura K., Fujibuchi W., Unno M. Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis 2012, 33:2311-2319.
28. Mojica W., Hawthorn L. Normal colon epithelium: a dataset for the analysis of gene expression and alternative splicing events in colon disease. BMC Genomics 2010, 11:5.
29. Morris A.R., Bos A., Diosdado B., Rooijers K., Elkon R., Bolijn A.S., Carvalho B., Meijer G.A., Agami R. Alternative cleavage and polyadenylation during colorectal cancer development. Clin. Cancer Res. 2012, 18:5256-5266.
30. Narita M., Murata T., Shimizu K., Nakagawa T., Sugiyama T., Inui M., Hiramoto K., Tagawa T. A role for cyclic nucleotide phosphodiesterase 4 in regulation of the growth of human malignant melanoma cells. Oncol. Reports 2007, 17:1133-1139.
31. O'Connell M.J., Lavery I., Yothers G., Paik S., Clark-Langone K.M., Lopatin M., Watson D., Baehner F.L., Shak S., Baker J., Cowens J.W., Wolmark N. Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. J. Clin. Oncol. 2010, 28:3937-3944.
32. Ogino S., Goel A. Molecular classification and correlates in colorectal cancer. J. Mol. Diag. JMD 2008, 10:13-27.
33. Pal S., Gupta R., Davuluri R.V. Alternative transcription and alternative splicing in cancer. Pharmacol. Ther. 2012, 136:283-294.
34. Pan Q., Shai O., Lee L.J., Frey B.J., Blencowe B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008, 40:1413-1415.
35. Pizzini S., Bisognin A., Mandruzzato S., Biasiolo M., Facciolli A., Perilli L., Rossi E., Esposito G., Rugge M., Pilati P., Mocellin S., Nitti D., Bortoluzzi S., Zanovello P. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 2013, 14:589.
36. Purdom E., Simpson K.M., Robinson M.D., Conboy J.G., Lapuk A.V., Speed T.P. FIRMA: a method for detection of alternative splicing from exon array data. Bioinformatics 2008, 24:1707-1714.
37. Ritchie W., Granjeaud S., Puthier D., Gautheret D. Entropy measures quantify global splicing disorders in cancer. PLoS Comput. Biol. 2008, 4:e1000011.
38. Sheffer M., Bacolod M.D., Zuk O., Giardina S.F., Pincas H., Barany F., Paty P.B., Gerald W.L., Notterman D.A., Domany E. Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc. Natl. Acad. Sci. U S A 2009, 106:7131-7136.
39. Shkreta L., Froehlich U., Paquet E.R., Toutant J., Elela S.A., Chabot B. Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes. Mol. Cancer Ther. 2008, 7:1398-1409.
40. Sveen A., Bakken A.C., Agesen T.H., Lind G.E., Nesbakken A., Nordgard O., Brackmann S., Rognum T.O., Lothe R.A., Skotheim R.I. The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer. Int. J. Cancer. J. Int. Cancer 2012, 131:1479-1485.
41. Taft R.J., Simons C., Nahkuri S., Oey H., Korbie D.J., Mercer T.R., Holst J., Ritchie W., Wong J.J., Rasko J.E., Rokhsar D.S., Degnan B.M., Mattick J.S. Nuclear-localized tiny RNAs are associated with transcription initiation and splice sites in metazoans. Nature Struct. Mol. Biol. 2010, 17:1030-1034.
42. Tazi J., Bakkour N., Stamm S. Alternative splicing and disease. Biochim. Biophys. Acta 2009, 1792:14-26.
43. Thompson P.M., Tolbert C.E., Campbell S.L. Vinculin and metavinculin: oligomerization and interactions with F-actin. FEBS Letters 2013, 587:1220-1229.
44. Thorsen K., Mansilla F., Schepeler T., Oster B., Rasmussen M.H., Dyrskjot L., Karni R., Akerman M., Krainer A.R., Laurberg S., Andersen C.L., Orntoft T.F. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway. Mol. Cell. Prot. MCP 2011, 10. M110 002998.
45. Thorsen K., Sorensen K.D., Brems-Eskildsen A.S., Modin C., Gaustadnes M., Hein A.M., Kruhoffer M., Laurberg S., Borre M., Wang K., Brunak S., Krainer A.R., Torring N., Dyrskjot L., Andersen C.L., Orntoft T.F. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol. Cell. Prot. MCP 2008, 7:1214-1224.
46. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., Freier S.M., Bennett C.F., Sharma A., Bubulya P.A., Blencowe B.J., Prasanth S.G., Prasanth K.V. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell. 2010, 39:925-938.
47. Turro E., Lewin A., Rose A., Dallman M.J., Richardson S. MMBGX: a method for estimating expression at the isoform level and detecting differential splicing using whole-transcript Affymetrix arrays. Nucl. Acids Res. 2010, 38:e4.
48. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
49. Ward A.J., Cooper T.A. The pathobiology of splicing. J. Pathol. 2010, 220:152-163.
50. Welinder C., Ekblad L. Coomassie staining as loading control in Western blot analysis. J. Prot. Res. 2011, 10:1416-1419.
51. Zardo G., Ciolfi A., Vian L., Billi M., Racanicchi S., Grignani F., Nervi C. Transcriptional targeting by microRNA-polycomb complexes: a novel route in cell fate determination. Cell Cycle 2012, 11:3543-3549.